ANDA 215146, held by Curium. Technetium TC-99M Pentetate Kit.
As of Nov 21, 2026, ANDA 215146 (Technetium TC-99M Pentetate Kit), held by Curium, was first approved by FDA on Mar 26, 2025, with 0 approved supplements and 0 published complete response letters.
Kit for the Preparation of Technetium Tc 99m Pentetate Injection, after radiolabeling with Technetium Tc 99m, is indicated for Kit for the Preparation of Technetium Tc 99m Pentetate Injection. Technetium Tc 99m pentetate is a radioactive diagnostic agent indicated for: Brain imaging in adults. Renal visualization, assessment of renal perfusion, and estimation of glomerular filtration rate in adult and pediatric patients. Lung ventilation imaging and evaluation of pulmonary embolism when paired with perfusion imaging in adult and pediatric patients. 1.1 Brain Imaging Brain imaging in adults by intravenous administration. 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 26, 2025 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Technetium TC-99M Pentetate KitN/A · injectable;injection | Technetium TC-99M Pentetate Kit | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters